Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries GeneDx Holdings Corp. - Class A Common Stock (NQ: WGS ) 35.52 -0.24 (-0.69%) Streaming Delayed Price Updated: 12:32 PM EDT, Aug 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about GeneDx Holdings Corp. - Class A Common Stock < Previous 1 2 3 4 5 Next > GeneDx to Participate in Fall Investor Conferences August 12, 2024 From GeneDx Via Business Wire GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) August 09, 2024 From GeneDx Via Business Wire WGS Stock Earnings: GeneDx Hldgs Beats EPS, Beats Revenue for Q2 2024 July 30, 2024 WGS stock results show that GeneDx Hldgs beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. Via InvestorPlace GeneDx Announces Whole Genome Sequencing (WGS) Product Enhancements to Accelerate Diagnoses for More Patients July 30, 2024 From GeneDx Via Business Wire Expert Ratings For GeneDx Hldgs July 17, 2024 Via Benzinga The Latest Analyst Ratings For GeneDx Hldgs June 26, 2024 Via Benzinga GeneDx Reports Second Quarter 2024 Financial Results and Business Highlights July 30, 2024 From GeneDx Via Business Wire GeneDx Leads Russell 2000 This Year As It Shifts To More Comprehensive Genetic Testing July 18, 2024 GeneDx Holdings Corp. (NASDAQ: WGS) has soared 1,101% this year, attributed to its mix shift towards exome/genome testing and record high margins. Via Benzinga GeneDx to Report Second Quarter 2024 Financial Results on Tuesday, July 30, 2024 July 11, 2024 From GeneDx Holdings Corp. Via GlobeNewswire 7 Small-Cap Stocks With Massive Potential Returns July 06, 2024 Explore these small-cap stocks with high potential in health care, REITs, entertainment, hardware, finance, and distribution industries. Via InvestorPlace GeneDx Announces Collaboration with Epic Aura to Expand Access to Rapid Whole Genome Sequencing (rWGS) Services to Inform Diagnosis in Affected Pediatric and Neonatal Patients June 10, 2024 From GeneDx Holdings Corp. Via GlobeNewswire Over $12M Bet On PBF Energy? Check Out These 3 Stocks Insiders Are Buying June 06, 2024 Via Benzinga GeneDx Announces Patient Access Program to Expand Access to Exome Testing for Pediatric Epilepsy Patients June 05, 2024 From GeneDx Holdings Corp. Via GlobeNewswire Over $4M Bet On ProFrac Holding? Check Out These 3 Stocks Insiders Are Buying May 29, 2024 Via Benzinga GeneDx to Participate in Upcoming Investor Conferences May 22, 2024 From GeneDx Holdings Corp. Via GlobeNewswire Over $1M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying May 16, 2024 Via Benzinga Gold Down Over 2%; 3M Profit Beats Expectations April 30, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session April 30, 2024 Via Benzinga Eli Lilly Increases FY24 Outlook, Joins Brinker International, Zebra Technologies, 3M And Other Big Stocks Moving Higher On Tuesday April 30, 2024 Via Benzinga Why H&E Equipment Services Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session April 30, 2024 Via Benzinga Why GeneDx Shares Are Trading Higher By 37%; Here Are 20 Stocks Moving Premarket April 30, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session April 30, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday April 30, 2024 Our coverage for Tuesday starts with a dive into the biggest pre-market stock movers traders will want to keep an eye on today! Via InvestorPlace WGS Stock Earnings: GeneDx Hldgs Beats EPS, Beats Revenue for Q1 2024 April 29, 2024 WGS stock results show that GeneDx Hldgs beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. Via InvestorPlace GeneDx Stock Climbs After Better-Than-Expected Q1 Results, Raises FY24 Guidance April 29, 2024 GeneDx reports quarterly losses of 33 cents per share which beat the analyst consensus estimate of losses of 67 cents by 50.75%. The company reported quarterly sales of $62.422 million which beat the... Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session April 29, 2024 Via Benzinga GeneDx Reports First Quarter 2024 Financial Results and Business Highlights April 29, 2024 From GeneDx Holdings Corp. Via GlobeNewswire GeneDx Announces Partnership with Komodo Health to Expand Access to World’s Largest Rare Disease Dataset April 23, 2024 The Company will also participate in a World Orphan Drug Congress panel presentation highlighting the role of genomic sequencing in advancing precision medicine From GeneDx Holdings Corp. Via GlobeNewswire GeneDx to Report First Quarter 2024 Financial Results on Monday, April 29, 2024 April 04, 2024 From GeneDx Holdings Corp. Via GlobeNewswire 12 Health Care Stocks Moving In Tuesday's Pre-Market Session March 19, 2024 Via Benzinga < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
